[
    [
        {
            "time": "",
            "original_text": "“两针有效 三针更优” 智飞生物新冠疫苗生产、研发将常态化",
            "features": {
                "keywords": [
                    "智飞生物",
                    "新冠疫苗",
                    "生产",
                    "研发",
                    "常态化"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "“两针有效 三针更优” 智飞生物新冠疫苗生产、研发将常态化",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "【股东大会直击】智飞生物董事长蒋仁生：重组新冠疫苗供不应求，天天有人等着要",
            "features": {
                "keywords": [
                    "智飞生物",
                    "重组新冠疫苗",
                    "供不应求",
                    "蒋仁生"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【股东大会直击】智飞生物董事长蒋仁生：重组新冠疫苗供不应求，天天有人等着要",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "疫苗板块回暖，康华生物涨超5%",
            "features": {
                "keywords": [
                    "疫苗板块",
                    "康华生物",
                    "涨超5%"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "疫苗板块回暖，康华生物涨超5%",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]